Congressionally Directed Medical Research Programs -- Ovarian Cancer Research Program -- Clinical Development Award

Funding Agency:
Department of Defense

The OCRP Clinical Development Award is intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life.

The goal of this award mechanism is to accelerate the clinical introduction of medical products and technologies that target ovarian cancer biology. Near-term clinical impact is expected. Proof of concept demonstrating the potential utility of the proposed product or a prototype/ preliminary version of the proposed product should already be established; thus, preclinical studies in animals are not allowed. Small-scale clinical trials (Phase 0, Phase 1), studies enriching a clinical trial, and projects related to or associated with ongoing or completed clinical trials are allowed. Relevant data, either published or unpublished, that support the study rationale are required. 

• Pre-Application Deadline: April 30, 2019
• Invited Application Submission Deadline: July 31, 2019

Agency Website

Eligibility Requirements

Independent investigators at or above the level of Assistant Professor (or equivalent) are eligible to submit applications.

For applications with an optional nested Early-Career Investigator: • An Early-Career Investigator is defined as an investigator within 5 years of his/her last postdoctoral research position (Ph.D.), clinical fellowship (M.D.), or equivalent at the full application submission deadline. • Can only be selected if a clinical trial is being proposed. • A Statement of Eligibility for the Early-Career Investigator is required with the submission of the full application.

An eligible PI, regardless of ethnicity, nationality, or citizenship status, must be employed by, or affiliated with, an eligible organization.



Amount Description

The anticipated direct costs budgeted for the entire period of performance for an FY19 OCRP Clinical Development Award will not exceed $600,000, and the anticipated direct costs budgeted for the entire period of performance for an FY19 OCRP Clinical Development Award with an optional nested Early-Career Investigator will not exceed $800,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information. The Government reserves the right to fund an application at a lower funding level if it does not meet the eligibility criteria or intent of the optional feature.

Funding Type



Junior Faculty


Medical - Clinical Science
Medical - Translational

External Deadline

April 30, 2019